FDA Grants Accelerated Approval for OTOF Gene Therapy - Quiz - MDSpire

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.

  • By

  • Kathryn Wighton

  • April 23, 2026

  • 3 min

Share

Original Source(s)

FDA Grants Accelerated Approval for OTOF Gene Therapy

  • by Kathryn Wighton

  • April 23, 2026

Related Content

Systemic Glucocorticoid Treatment for Cutaneous Rosai-Dorfman Disease Affecting the Left Ear: A Case Study

Correction: Migrainous vertigo impairs adaptive learning as a function of uncertainty

Association of residential altitude with pure-tone hearing thresholds in plateau residents aged ≤50 years: a cross-sectional study